Purpose. The aim of this study was to compare the diagnostic accuracy of 2-[fluorine-18] fluoro-2-deoxy-Dglucose positron emission tomography ( 18 F-FDG-PET) and computed tomography (CT) with PET/CT in the detection of liver metastases during tumour staging in patients suffering from colorectal carcinoma for the purposes of correct surgical planning and follow-up. Materials and methods. A total of 467 patients underwent a PET/CT scan using an iodinated contrast medium. We compared images obtained by the single PET scan, the single CT scan and by the fusion of the two procedures (PET/CT). specificity, enabling modification of patient treatment, but it is also a unique, high-profile procedure that can produce cost savings.
Introduction
Colorectal cancer has an elevated incidence in Western countries and is the second most frequent cause of death from cancer in both genders in Europe and the United States [1] . In Italy there are approximately 46,000 new cases each year, with a 5-year survival rate of 58% [2] . Liver metastases are a common occurrence in the history of patients affected by colorectal cancer, with an incidence of 20% at the time of diagnosis and >50% during the course of the disease [3] . In 15%-30% of cases, the metastases manifest exclusively in the liver at the same time or months or years after diagnosis of the primary tumour of the colon or rectum. The natural history of the disease shows that once they have been identified, liver metastases are destined to increase in size and number.
Hepatic resection of metastatic lesions is considered the most effective treatment option in terms of increased survival [4, 5] , although few patients are able to undergo radical surgery at the time of diagnosis (owing to lesion site, multifocal involvement and/or insufficient residual liver function), and the 5-year survival rate after surgery is only 20%-50% [6] . Indeed, following surgical resection of liver metastases, many patients present with local tumour recurrence months after surgery. Tumour recurrence and surgical failure may be due to inadequate initial evaluation of the metastatic disease. Performing a detailed preoperative diagnostic study is therefore of prime importance for accurately defining the exact number and precise location of hepatic metastases. To date, the imaging modalities used for this purpose have been ultrasonography, contrast-enhanced computed tomography (CT) and magnetic resonance imaging (MRI). However, given the poor long-term results obtained, these modalities are evidently unable to guarantee an accurate preoperative assessment [7] .
The impact of positron emission tomography (PET) on the quality of pretreatment diagnostic staging has been demonstrated in many tumours, including colorectal carcinoma. Retrospective studies have shown that PET provides a better preoperative selection of patients with colorectal cancer and secondary lesions, which after resection of liver garantendo così un'anticipazione diagnostica. La PET/TC non solo offre una performance diagnostica ottimale in termini di sensibilità e specificità, permettendo peraltro di modificare l'iter terapeutico del paziente, ma riveste anche caratteri di indagine unica di elezione, con conseguenti risparmi economici.
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Introduzione
Il cancro del colon-retto presenta un'elevata incidenza nel mondo occidentale ed è la seconda causa di mortalità per neoplasia in ambedue i sessi sia in Europa che negli Stati
Uniti [1] . In Italia, in particolare, i nuovi casi sono ogni anno circa 46000 con sopravvivenza a 5 anni del 58% [2] . Nella storia dei pazienti affetti da neoplasia del colon-retto, le metastasi epatiche rappresentano un'evenienza comune, presentandosi nel 20% dei casi al momento della diagnosi ed in oltre il 50% nel corso della malattia [3] . Nel
15%-30% dei casi le metastasi si manifestano esclusivamente al fegato contestualmente o a distanza di mesi o di anni dal momento della diagnosi del tumore primitivo del colon o del retto. La storia naturale della malattia indica che, una volta individuate, le metastasi epatiche sono destinate ad accrescersi di volume e ad aumentare di numero.
La resezione epatica delle lesioni metastatiche è l'approccio terapeutico finora ritenuto più efficace in termini di aumento della sopravvivenza [4, 5] , ma solo pochi pazienti sono radicalmente operabili al momento della diagnosi (in relazione alla localizzazione, al coinvolgimento multifocale e/o in ragione di una insufficiente funzionalità epatica residua) e la sopravvivenza a 5 anni dopo la chirurgia è solo del 20%-50% [6] [7] .
L'impatto della PET (tomografia a emissione di positroni) sulla qualità dello staging diagnostico pre-terapeutico metastases translates into longer survival [8] . Due to its intrinsic characteristics as a functional examination, PET is in fact able to provide functional characterisation of the lesions. This occurs because the tracer used -usually 2-[fluorine-18] fluoro-2-deoxy-D-glucose ( 18 F-FDG), a glucose analogue labelled with fluorine -is avidly taken up by the neoplastic cells, which have a more active glucose metabolism than normal cells [9] . The metabolic information provided by FDG-PET can therefore be used to obtain a more accurate definition of the areas of malignancy and possible lymph-node involvement, as well as identifying distant metastases, as the examination provides a full-body scan [10] . Furthermore, functional/metabolic alterations can be demonstrated and located earlier than the information provided by other imaging modalities, which are based purely on anatomical dimensional criteria or vascular abnormalities. The limited morphological information provided by PET, however, creates the need for integration with conventional CT. The introduction of new hybrid PET/CT scanners is in this sense a great leap forward [11] [12] [13] .
The aim of this study was to compare the diagnostic accuracy of 18 F-FDG-PET, CT and PET/CT in the detection of liver metastases during staging and follow-up of patients with colorectal cancer.
Materials and methods
The study involved patients referred to our department between April 2005 and December 2007 with a diagnosis of colorectal cancer and suspected liver metastases. All patients were examined with PET, contrast-enhanced CT and PET/CT. The definitive diagnosis was provided by histology and/or clinical/radiological follow-up in all patients, even those who did not undergo biopsy or surgical procedures.
PET/CT examination technique
All examinations were performed with an integrated PET/CT scanner, Discovery ST (GE, General Electric Medical Systems, Milwaukee, WI, USA). The system combines a high speed ultra 16-detector-row CT scanner with a PET scanner equipped with 10080 bismuth germinate crystals arranged in 24 rings. Patients were required to fast for at least 6 h prior to the examination. Before injection of the radiotracer, patients' blood glucose levels were evaluated, and 18 F-FDG was injected only in conditions of normal glycaemia to avoid reducing the diagnostic potential of PET as a result of the competitive effect created by high blood glucose levels. In the event of hyperglycaemia, the patient was invited to temporarily increase muscular activity to bring blood glucose below 150 mg/dl. A single 370-MBq dose of radiotracer was administered intravenously 45-60 è stato evidenziato in molti tumori, incluso il carcinoma del colon-retto. Studi retrospettivi hanno dimostrato che la PET permette una migliore selezione pre-operatoria dei pazienti con tumore del colon-retto con localizzazioni secondarie, che si traduce, dopo la resezione di metastasi epatiche, con una più lunga sopravvivenza [8] . La [11] [12] [13] .
Lo scopo di questo studio è comparare l'accuratezza diagnostica della 18 min before the examination. During this phase, the patient was kept in a quiet environment to limit muscle activity and thereby reduce radiotracer accumulation in skeletal muscle. The patient was also adequately hydrated with intravenous saline solution (250-500 ml) to reduce pooling of the radiotracer in the renal collecting system. At the same time, a single dose of approximately 900 cc of a solution containing contrast material (Gastrografin-370 mgI/ml, Schering AG, Berlin, Germany) was administered orally to adequately opacify the bowel loops according to a protocol implemented in the department.
The examination was performed with the patient lying supine inside the gantry with arms above the head and began with a scout scan. A baseline CT scan was then acquired with low tube current (80 mA) to correct the attenuation for the PET study. The following scan parameters were used: 140 kV to obtain good quality images at the level of the shoulder and pelvic girdles; 80 mA; FOV 420-500 mm; CT slice thickness 3.75 mm (retrospectively reconstructed to 1.25 mm) to approximate the width of the PET section; slice interval 3.27 mm, to coincide with the spacing between the PET sections; scan speed <1 s per revolution. Once the CT scan was completed, the PET scan was performed with a 2D technique in the caudocranial direction from the proximal third of the femurs to the head; five to six bed positions were acquired, with a duration of 4 min per bed.
Images were reconstructed using a standard iterative algorithm [ordered subsets expectation maximisation (OSEM)], with a mean duration for the PET examination of 20-24 min. PET acquisition was immediately followed by CT examination performed with the intravenous administration of 100-120 ml of nonionic iodinated contrast medium with an injection rate of 2-3 ml/s (Iomeron-350 mgI/ml, Bracco, Milan, Italy). Two data sets were acquired: the first included the upper abdomen with a delay of 30 s from the beginning of the contrast injection, and the second extended from the neck to the pubic symphysis with a delay of 60-80 s. An additional scan was performed in the late phase to correctly characterise the lesions. Lastly, after having the patients place their arms by their sides, axial scans of the head were acquired.
The following scan parameters were used: 120-140 kV, automatic tube current (limit 330-350 mA), slice thickness 3.75 mm (retrospectively reconstructed to 1.25), acquisition mode 27.50/1.375:1, gantry rotation speed 0.6 s, FOV large, matrix 512×512. The overall duration of the entire PET/CT acquisition was on average 40 min. PET/CT fusion software. PET images were assessed for areas of increased focal metabolism that exceeded the accumulation of tracer in the anatomical region. The analysis was conducted on the images corrected for attenuation and in the case of doubt also on the uncorrected images. Acquisition data of all CT examinations were processed and retrospectively reconstructed with the following parameters: slice thickness 1.25 mm and interval 3.27 mm to coincide with the spacing between the PET sections. Attenuation changes of the lesions were then quantified in both baseline conditions and after contrast enhancement.
Images obtained with CT and PET were independently reviewed by a radiologist and nuclear physician in a doubleblind fashion. Finally, diagnostic concordance between the two techniques was assessed by another group of three radiologists and three nuclear physicians. The following criteria were considered as positive findings: evidence of at least one focal uptake of FDG in the liver on PET, and the finding of at least one focal lesion suspected to be a metastatic lesion (Figs. 1, 2) . 
Statistical analysis
Data analysis was performed on the basis of the positive findings in the individual patient. For each imaging modality, we evaluated sensitivity, specificity and diagnostic accuracy with 95% confidence intervals (95% CI test. In addition, we also calculated the positive predictive values (PPV) and negative predictive values (NPV) with the corresponding 95% CI.
Results
The study population included 467 subjects (301 men and 166 women) with a mean age of 64.4±10.2 years (M 66.2±10.7, F 61.2±95) ( Table 1) . The PET/CT study was conducted on all patients to identify the presence of liver metastases during staging and follow-up. Definitive diagnosis was provided by histological examination and/ or by the follow-up of all patients, even those who did not undergo biopsy or surgery. In 426 cases (91.2%), there was concordance among the three modalities (PET, CT and PET/CT) (Figs. 1, 2) . A total of 336 patients (72%) were diagnosed as having at least one metastatic lesion in the liver at subsequent examinations [true positives (TP)].
In addition, a negative finding not in agreement with the later examinations [false negative (FN)] was obtained in 57 (12.2%) cases. These were broken down as follows: 30 (6.4%) FN cases at CT because no corresponding anatomical alteration was yet visible (Fig. 3) ; 20 (4.3%) FN at PET due to the small lesion size (<10 mm), mucinous content or marked central necrosis (Fig. 4) ; seven (1.5%) FN at PET/CT resulting from the above-mentioned variables. Twenty cases (4.3%) of false positives (FP) were identified at follow-up and/or biopsy: 11 at PET (2.4%), six at CT (Fig. 3) (Fig. 4) patients with colorectal cancer have secondary liver lesions at diagnosis, and 20% of patients develop them thereafter. Surgical excision of the lesions combined with chemotherapy is the treatment strategy able to guarantee a more satisfactory survival rate, even though only one third of liver metastases are treatable.
Risultati
Lo studio ha riguardato 467 soggetti (301 maschi e 166 femmine) di età media 64,4 anni±10,2 (M 66,2±10,7, F 61,2±9,5) (Tabella 1). La PET/TC è stata effettuata in tutti i pazienti con l'intento di identificare la presenza di metastasi epatiche sia in fase di stadiazione che di follow-up. La diagnosi definitiva è stata ottenuta mediante conferma istologica e/o attraverso il follow-up di tutti i pazienti, anche di quelli non sottoposti a procedure bioptiche o ad intervento chirurgico. In 426 casi (91,2%) si è ottenuto un reperto concorde per tutte le metodiche (PET, TC e PET/TC) (Figg. 1 e 2). I pazienti in cui è stata evidenziata almeno una metastasi epatica ai controlli successivi (veri positivi, VP) sono stati 336 (72% del totale). Si è ottenuto, inoltre, un reperto negativo (falsi negativi, FN), non conforme ai successivi controlli, per le metodiche PET, TC e PET/TC rispettivamente in 20 (4,3%), 30 (6,4%) e 7 (1,5%) casi. I risultati discordanti rispetto ai successivi follow-up hanno dimostrato: 30 casi FN alla TC poiché non era ancora visibile un'alterazione anatomica corrispondente
; 20 casi FN alla PET dovuti alle dimensioni delle lesioni (<10 mm), al contenuto mucinoso o all'importante necrosi centrale
In the study of colorectal cancer, PET has been utilised mainly to clarify the nature of dubious lesions identified on a first-line examination such as CT or when -especially during follow-up -an increase in a tumour marker is seen in the absence of lesions demonstrated by the more conventional diagnostic examinations [14] . The high level of clinical transferability of the information provided by PET Nello studio delle neoplasie del colon-retto, la PET è stata di solito impiegata allo scopo di chiarire la natura di lesioni dubbie già evidenziate da esami di I livello come la TC oppure quando, soprattutto in corso di follow-up, si osservava un incremento di un marcatore oncologico, in assenza di localizzazioni documentate dai più convenzionali esami diagnostici [14] . L'elevata trasferibilità clinica dell'informazione fornita dalla PET dipende dalla capacità di valutare il grado di attività metabolica dei tessuti tumorali, non considerando esclusivamente i parametri morfologici e dimensionali delle lesioni.
Numerosi studi hanno dimostrato che il tessuto neoplastico in rapida crescita utilizza il glucosio come substrato ai F-FDG is widely used in the study of many malignant diseases [16, 17] , as it is considered better than conventional imaging in identifying primary or secondary tumours.
In our study, we sought to compare the functional and morphological information obtained from 18 F-FDG PET and CT with that provided by PET/CT in the evaluation of secondary hepatic lesions. Our results showed similar sensitivity, specificity and diagnostic accuracy values between the two modalities and an improvement when the two techniques are used in combination. The Z test failed to demonstrate statistically significant differences between the two individual modalities and showed that PET and CT were very much alike in their detection of liver metastases. In contrast, combined PET/CT proved superior to PET and CT used individually, with statistically significant differences in all the parameters studied except CT specificity.
In our study there was greater concordance among imaging modalities in terms of sensitivity, specificity and diagnostic accuracy than reported in the literature, as most studies to date have used CT without contrast enhancement, which does not enable visualisation of many liver metastases [17] [18] [19] . Even if secondary hepatic lesions show evident focal uptake of 18 F-FDG on the PET images, these lesions often cannot be identified on baseline CT images. In our study, contrast-enhanced CT improved diagnostic reliability above all for the purposes of correct preoperative staging without negatively influencing the qualitative and quantitative data obtained at PET.
Although PET and CT are shown by the data to be equivalent in their ability to identify secondary hepatic lesions, the two modalities are evidently complementary. In agreement with the literature, the integration of PET with CT makes possible the combination of metabolic data and morphological imaging, thus enabling an accurate definition of the extension of disease at the time of diagnosis [20, 21] . The combined technique in fact offers improved localisation of the foci of radiotracer uptake, differentiating the increases in metabolic activity due to physiological or inflammatory processes from those of neoplastic origin [22, 23] . In addition, it improves the localisation and characterisation of lesions [24] , thus reducing the number of lesions of uncertain or indefinite origin.
The evaluation of treatment response is also improved by not relying solely on size criteria. Indeed, studies have shown that the reduction in the number of malignant cells fini energetici, determinando un aumento dell'uptake del 18 F-FDG [15] . Sebbene tale tracciante non sia specifico della cellula tumorale, la 18 F-FDG-PET risulta largamente utilizzata nello studio di molte patologie neoplastiche [16, 17] [20, 21] . La tecnica combinata permette infatti una migliore localizzazione dei foci di uptake, differenziando gli aumenti di attività metabolica di natura fisiologica o flogistica da quelli di natura neoplastica [22, 23] . Inoltre migliora la localizzazione delle lesioni ed aumenta la loro caratterizzazione [24] , riducendo il numero di lesioni con origine incerta o equivoca.
Migliora anche la valutazione della risposta alla terapia, che sulla base di soli criteri dimensionali può risultare inaccurata. Infatti, è noto che la riduzione del numero delle may not lead to a significant reduction in lesion size, as the neoplastic tissue may be replaced by necrotic tissue or fibrosis, which cannot be differentiated from malignant tissue with conventional diagnostic modalities. In addition, treatment planning may be oriented and/or modified by fusion of the metabolic data provided by PET, which is fundamental for identifying secondary lesions located in the peritoneum, mesentery and lymph nodes [25] where CT shows its major limitations -with the morphological data provided by CT -which makes possible the examination of fundamental anatomical structures such as the portal vein, the vena cava or the bile ducts [26] .
Accurate preoperative staging is crucial for determining the optimal therapeutic approach in each patient [27] . The combined technique, which is able to perform precise tumour staging, can orient or rule out the need for further procedures, thus changing the treatment plan [18, [28] [29] [30] . PET/CT has proven particularly effective even when clinical or imaging techniques fail to demonstrate disease recurrence in the presence of a progressive increase in tumour markers, thus leading to an earlier diagnosis with a positive impact on patient survival. The change in the uptake of 18 F-FDG in fact correlates with serum carcinoembryonic antigen levels, the increase in which is a common finding in these patients [25] .
The combined modality also minimises the intrinsic limitations of the two techniques responsible for FN findings. In our experience, at CT these are prevalently due to the lack of evident anatomical alterations or vascular abnormalities in the presence of increased neoplastic metabolic activity (Fig. 3) , and at PET to the presence of necrotic areas with no radiotracer uptake, mucinous adenocarcinoma metastases [31] or lesions smaller than the technique's resolution power, which instead are identifiable with contrastenhanced CT (Fig. 4) .
Although PET is an expensive technique that is not available in all centres, a cost-benefit analysis performed in the United States and Europe showed that PET/CT enables improved patient selection for surgery and as a result is cost effective [32] . Moreover, the use of PET/CT leads to an overall reduction in costs with respect to the separate use of the two imaging modalities [33] and improved utilisation of the diagnostic devices [34] . Lastly, by optimising study protocols, the combined PET/CT examination is also able to reduce the overall dose of radiation delivered to the patient [33] and the overall examination time, thus minimising patient discomfort.
Conclusions
of the data obtained with the two modalities taken individually. The technique therefore plays a crucial role in the staging and follow-up of cancer patients. The use of PET/CT may be instrumental in reaching an earlier diagnosis, which influences patient management by prompting the performance of procedures of proven effectiveness or the nonperformance of procedures that may prove ineffective or even harmful. PET/CT offers excellent diagnostic performance in terms of sensitivity and specificity and can modify a patient's treatment protocol. Lastly, the technique has the characteristic of an all-in-one examination if performed with contrast medium, thus leading to significant economic savings. 
